Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 May;21(5):230-5.
doi: 10.1007/s12471-013-0386-y.

Treatment costs of acute myocardial infarction in the Netherlands

R R Soekhlal  1 , L T Burgers, W K Redekop, S S Tan
Affiliations

Treatment costs of acute myocardial infarction in the Netherlands

R R Soekhlal et al. Neth Heart J. 2013 May.

Abstract

Background: This study aimed to calculate the treatment costs of acute myocardial infarction (AMI) in the Netherlands for 2012. Also, the degree of association between treatment costs of AMI and some patient and hospital characteristics was examined.

Methods: For this retrospective cost analysis, patients were drawn from the database of the Diagnosis Treatment Combination (Diagnose Behandeling Combinatie, DBC) casemix system, which contains data on the resource use of all hospitalisations in the Netherlands. All costs were based on Euro 2012 cost data.

Results: The analysis was based on data of 25,657 patients. Mean treatment costs were estimated at <euro> 5021, with significant cost increases for patients with percutaneous coronary intervention (PCI) treatment. ST-segment elevation myocardial infarction (STEMI) patients receiving thrombolysis incurred the lowest (<euro> 4286), while non-STEMI patients receiving PCI the highest costs (<euro> 6060). Length of stay and hospital type were strong predictors of treatment costs.

Conclusions: This study is the most extensive cost assessment of the treatment costs of AMI in the Netherlands thus far. Our results may be used as input for health-economic models and economic evaluations to support the decision making of registration, reimbursement and pricing of interventions in healthcare.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Breakdown of treatment costs for the total population and by patient subgroup (Euro 2012). STEMI ST segment elevation myocardial infarction, PCI percutaneous coronary intervention. * laboratory services, medical imaging services, surgical procedures (except catheterization and PCI procedure), medical devices (except coronary stent), diagnostic activities, microbiological and parasitological services, pathology, blood products, paramedical and supportive services and rehabilitation services
None
See this image and copyright information in PMC

References

    1. Keeley EC, Hillis LD. Primary PCI for myocardial infarction with ST-segment elevation. N Engl J Med. 2007;356:47–54. doi: 10.1056/NEJMct063503. - DOI - PubMed
    1. Poos MJJC. Volksgezondheid Toekomst Verkenning, Nationaal Kompas Volksgezondheid. RIVM: Bilthoven; 14 juni 2012.
    1. Voss GB, Hasman A, Rutten F, et al. Explaining cost variations in DRGs ‘Acute Myocardial Infarction’ by severity of illness. Health Pol. 1994;28:37–50. doi: 10.1016/0168-8510(94)90019-1. - DOI - PubMed
    1. Evans E, Imanaka Y, Sekimoto M, et al. Risk adjusted resource utilization for AMI patients treated in Japanese hospitals. Health Econ. 2007;16:347–59. doi: 10.1002/hec.1177. - DOI - PubMed
    1. Hamm CW, Bassand JP, Agewall S, et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J. 2011;32:2999–3054. doi: 10.1093/eurheartj/ehr236. - DOI - PubMed

LinkOut - more resources